Smartleaf Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Buy
56,007
+2,386
+4% +$556K 0.49% 39
2025
Q4
$11.1M Buy
53,621
+7,567
+16% +$1.5M 0.42% 43
2025
Q3
$8.36M Buy
46,054
+8,339
+22% +$1.43M 0.52% 34
2025
Q2
$5.75M Buy
37,715
+649
+2% +$99.8K 0.51% 41
2025
Q1
$6.07M Buy
37,066
+3,496
+10% +$547K 0.59% 31
2024
Q4
$4.81M Buy
33,570
+1,942
+6% +$301K 0.49% 34
2024
Q3
$5.1M Buy
31,628
+5,152
+19% +$821K 0.62% 26
2024
Q2
$3.86M Buy
26,476
+2,819
+12% +$419K 0.63% 28
2024
Q1
$3.74M Buy
23,657
+5,097
+27% +$811K 0.72% 26
2023
Q4
$2.89M Buy
+18,560
New +$2.85M 0.77% 29

Other funds holding JNJ

Smartleaf Asset Management's JNJ Position: Q1 2026 in Review

Smartleaf Asset Management increased its Johnson & Johnson (JNJ) stake by 4.4% in Q1 2026, buying an estimated $556K and bringing the position to 56,007 shares worth $13.6M. The position accounts for 0.49% of the portfolio, ranked #39.

Smartleaf Asset Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Smartleaf Asset Management held 56,007 shares of Johnson & Johnson worth $13.6M as of Q1 2026.
  • Smartleaf Asset Management bought 2,386 Johnson & Johnson shares in Q1 2026, an estimated $556K.
  • Johnson & Johnson made up 0.49% of Smartleaf Asset Management's portfolio in Q1 2026, its #39 holding.
  • Smartleaf Asset Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.